Improved production of riboflavin

US2022010291A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022010291-A1
Application numberUS-201917293800-A
CountryUS
Kind codeA1
Filing dateNov 11, 2019
Priority dateNov 15, 2018
Publication dateJan 13, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at least about 5%.

First claim

Opening claim text (preview).

1 . A riboflavin-producing host cell comprising riboflavin biosynthetic genes (rib operon) and a heterologous enzyme with pyridoxal phosphatase [EC 3.1.3.74] activity. 2 . The riboflavin-producing host cell of claim 1 comprising the riboflavin biosynthetic genes from Bacillus. 3 . The riboflavin-producing host cell of claim 1 comprising a polypeptide with at least about 70% identity to SEQ ID NO:2. 4 . The riboflavin-producing host cell according to claim 3 , expressing a polynucleotide encoding a polypeptide with at least 70% identity to SEQ ID NO:2. 5 . The riboflavin-producing host cell according to claim 1 , wherein the heterologous enzyme is selected from bacteria, preferably Rhizobia , more preferably Sinorhizobium. 6 . The riboflavin-producing host cell according to claim 1 , wherein the activity of the endogenous ribC gene has been reduced. 7 . The riboflavin-producing host cell according to claim 1 producing wherein the yield of riboflavin is increased by at least about 5% from a given carbon source compared to production of riboflavin using a host cell not expressing a polynucleotide encoding a polypeptide with at least 70% identity to SEQ ID NO:2. 8 . The riboflavin-producing host cell according to claim 1 , which is selected from Bacillus, Corynebacterium, Streptococcus, Clostridium, Lactococcus or Streptomyces , preferably selected from the group consisting of Bacillus subtilis, Bacillus cereus, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus halodurans, Bacillus licheniformis, Streptococcus aureus, Streptococcus pneumoniae, Clostridium acetobutylicum, Clostridium difficile, Lactococcus lactis, Streptomyces coelicolor, Corynebacterium diphteriae and Corynebacterium glutamicum. 9 . Process for production of riboflavin, wherein the riboflavin-producing host cell according to claim 1 is incubated in an aqueous medium under conditions that allow the production of riboflavin from a given substrate. 10 . The process according to claim 9 , wherein the yield of riboflavin is increased by at least 5% compared to a process wherein the host cell does not express a polynucleotide encoding a polypeptide with at least 70% identity to SEQ ID NO:2. 11 . A process according to claim 9 comprising the steps of: (a) providing a riboflavin-producing host cell according to any one of claims 1 to 7 , (b) incubating said host cell in an aqueous medium under conditions that allow the production of riboflavin from a given substrate, and optionally (c) isolating and purifying the riboflavin from the cultivation medium. 12 . Use of a polypeptide with at least 70% identity to SEQ ID NO:2 or of a riboflavin-producing host cell according to claim 1 in a process for production of riboflavin. 13 . A riboflavin-producing host cell comprising riboflavin biosynthetic genes (rib operon) and a heterologous enzyme having pyridoxal phosphatase activity [EC 3.1.3.74] used for a process for production of riboflavin.

Assignees

Inventors

Classifications

  • C12N9/16Primary

    acting on ester bonds (3.1) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Heterorings having nitrogen atoms as the only ring heteroatoms · CPC title

  • Pyridoxal phosphatase (3.1.3.74) · CPC title

  • C12P25/00Primary

    Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022010291A1 cover?
The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at least about 5%.
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C12N9/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).